Trademark Tussle: HC bars Glenmark from using Indamet, says similar to Sun Pharma's anti-diabetes drug Istamet Farhat Nasim22 April 2024 2:44 PM ISTNew Delhi: In a major respite to Sun Pharma Laboratories Ltd. , the Delhi High Court has upheld its previous ruling from July, affirming the...
Sun Pharma receives OAI status from USFDA for Dadra facility Ruchika Sharma12 April 2024 11:42 AM ISTMumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...
Sun Pharmaceutical Industries Gets CDSCO Panel Nod to Study FDC of Relugolix, Estradiol, Norethindrone Acetate Dr. Divya Colin8 April 2024 6:00 PM ISTNew Delhi: Rejecting for clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Sun Pharma Industries Gets CDSCO Panel Nod To Manufacture Market Elagolix Tablets 150 mg,200 mg Dr. Divya Colin6 April 2024 6:00 PM ISTNew Delhi: With the condition to be sold by retail under the prescription of a Gynaecologist only, pharmaceutical major Sun Pharma Industries has got...
Sun Pharmaceutical Industries appoints Dheeraj Sinha as Executive Vice President, Chief Information Officer Ruchika Sharma4 April 2024 11:30 AM ISTMumbai: Sun Pharmaceutical Industries Limited has appointed Dheeraj Sinha as Executive Vice President and Chief Information Officer effective from...
Drug safety alert: CDSCO flags 58 drug samples Roshni Dhar2 April 2024 5:06 PM ISTIn its latest drug safety alert, the apex drug regulatory body, the Central Standard Control Organisation (CDSCO) has flagged 58 medicine batches for...
CT waiver not considered, Conduct BA study: CDSCO Panel Tells Sun Pharma on Pulmonary FDC Dr. Divya Colin30 March 2024 6:00 PM ISTNew Delhi: Denying to consider the clinical trial waiver proposal for the fixed dose combination (FDC) Vilanterol Trifenatate plus Umeclidinium...
Sailesh T Desai retires from Sun Pharma Board of Directors Ruchika Sharma30 March 2024 11:52 AM ISTMaharashtra: Through a recent BSE filing, Sun Pharma has informed that Sailesh Trambaklal Desai will retire from the Company's Board of...
Sun Pharma gets Australian regulatory nod for acne vulgaris treatment Winlevi Susmita Roy19 March 2024 11:52 AM ISTWinlevi is approved for the topical treatment of acne vulgaris in people 12 years of age and older.
Sun Pharma recalls 55000 bottles of generic drug to treat gout from American market Ruchika Sharma12 March 2024 1:13 PM ISTThe affected lot was produced at Sun Pharma's Dadra-based plant for Memphis-based Northstar Rx LLC, the US regulator noted.
Sun Pharma unit recalls over 54000 bottles of Mesalamine ER capsules in US Ruchika Sharma9 March 2024 11:24 AM ISTThe affected lot of capsules have been manufactured by Sun Pharmaceutical Industries at its Mohali-based manufacturing plant and distributed in the US...
Justify bioequivalent data: CDSCO Panel Tells Sun Pharma on Mirabegron Extended-release Tablets Dr. Divya Colin8 March 2024 6:00 PM ISTNew Delhi: After reviewing the bioequivalence (BE) report of Mirabegron extended-release Tablets 50 mg presented by drug major Sun Pharma, the Subject...
